rioperative complications, however, may require care in an ICU. To our knowledge, there is no published report regarding the ICU outcome of patients with kidney transplantation.
The kidney is the most commonly transplanted solid organ, with nearly 10,000 transplants performed annually in the United States. For 
RESULTS
During the study period, 74 patients were admitted to the ICU for a total of 90 admissions. Complete data for three patients (six admissions) were unavailable leaving 71 patients (86 admissions) for final analysis. Twenty-one (29.6%) of these patients were 60 years old or older. Table 1 summarizes patient characteristics.
One hundred seventy-eight kidney transplants were performed during the study period. Twentyseven of these patients were admitted immediately after transplantation for monitoring (group 1). Twenty-one of them received their kidney transplant for the first time, one for the second, four for the third, and one for the fourth time. Three patients were receiving immunosuppressive therapy at the time of operation, two for previous heart transplantation and one for previous liver transplantation. Table 2 summarizes the reasons for the immediate postoperative admission to the ICU. History of cardiac disease was the most frequent reason (56%) for postoperative ICU admission. For this group, the mean ICU length of stay was 5.1 ± 7.5 days, the mean duration of mechanical ventilation was 2.8 ± 7.3 days, and the APACHE II score was 18±5. Seventeen of the 27 patients (63%) required renal replacement therapy during their ICU stay; seven of the 27 patients (26%) required mechanical ventilation. In this group, one patient died postoperatively in the ICU for a mortality rate of 3.7%. The hospital mortality for this group was identical to the ICU mortality, and below the predicted mortality rate of 15% calculated based on APACHE II.
The remaining 44 kidney transplant recipients were admitted to the ICU with various complications for a total of 59 admissions (group 2). The mean posttransplant time in these patients was 23±30 months. Four of the patients in this group were admitted after surgery unrelated to kidney transplantation (one after a native kidney nephrectomy, one after an operation for peripheral vascular disease, and two after a laparotomy for pancreatic pseudocysts). Admission diagnosis, mean ICU length of stay, APACHE II score, and mean duration of mechanical ventilation are summarized in Table 3 . Seven of 44 patients in this group died for a mortality of 16%. All seven patients received full therapeutic support before the withdrawal of life-sustaining measures. One of these seven patients, admitted to the ICU after cardiac arrest, died soon after the admission. The other six died of infection. Two of them, died of diffuse fungal infections with brain abscesses. The fungi were Cryptococcus neoformans in one patient and Pseudallescheria boydii in the other.
Four patients died of septic shock. For two of them, sepsis was the ICU admission diagnosis with the abdomen as a source of infection in one and a central venous line, growing Staphylococcus aureus, in the other. The two other patients, admitted for respiratory failure, died of Staphylococcus epidermidis bacteremia and septic shock. Sepsis was the ICU admission diagnosis in four other patients in this group but these patients survived (two with pneumococcal pneumonia and bacteremia, one with S aureus pneumonia, and one with urinary tract infection and bacteremia secondary to Escherichia coli). Hence, the infection was the most common reason of ICU admission (Table 3 ) and mortality in this group. Encephalopathy was the second most frequent reason for ICU admission. One case was attributed to tacrolimus toxicity, another to cyclosporine toxicity, and two cases to sedative medications. In other cases, the primary cause of encephalopathy could not be determined. In seven of these patients encephalopathy was accompanied by seizures. The three admissions with bleeding complications in this group were secondary to kidney biopsy, upper gastrointestinal tract bleeding, and retroperitoneal bleed (one case each). Miscellaneous admissions in this group were as follows (one case each): myocardial infarction, cardiac arrest, hypertension, loss of consciousness of undetermined etiology, pericardial effusion, pleural effusion, azotemia (blood urea nitrogen [BUN]=237 mg/dL, creatinine=42 mg/dL), hypotension during dialysis, and posttransplant lymphoproliferative disorders with sepsis syndrome. In this group, 13 patients (30%) required renal replacement therapy and 22 (50%) required mechanical ventilation.
The APACHE II score, duration of mechanical ventilation, and ICU length of stay were not significantly different between the two groups ( Table 4) . The overall ICU mortality in this study was 11% (8/ 71) . Two deaths occurred among the patients 60 years old or older for a mortality rate of 9%o (2/21), which was not higher than the mortality rate for the rest of the patients (6/50=12%). Two additional patients died in the hospital after discharge from the ICU, both patients from group 2, which brings the hospital mortality to 14% (10/71) for all the patients, and to 20% (9/44) for group 2 during the study period. The APACHE II score, mean duration of mechanical ventilation, mean length of ICU stay, admission BUN, and serum creatinine level for survivors and [27] [28] [29] [30] [31] [32] In the past decade, although the number of kidney transplants performed annually has remained relatively stagnant, there has been an incremental improvement in 1-year graft survival.1'2 In case of severe complications, an increasing number of these patients will be treated in the ICU.
To our knowledge, the outcome of renal transplant recipients in the ICU has not been previously reported. Our study shows that the ICU -mortality of these patients remained twice that of our general surgical ICU population. In group 1, the management of fluid and electrolyte abnormalities and prevention of cardiac ischemia have been the cornerstone of postoperative care in the ICU. The hospital outcome of these patients (group 1) was better than expected, and their actual hospital mortality rate (3.7%) was below the rate predicted by APACHE II (15%). This difference may be the reflection of a better preoperative evaluation of cardiopulmonary risk factors, postoperative monitoring of the patients with cardiac and pulmonary diseases, early admission to the ICU in case of complication, and progress in immunosuppressive therapy. We do not believe that this difference is related to a smaller sample size in our study compared with APACHE 11 (27 vs 47 postoperative patients in APACHE II). In group 2, 90% of the patients (except for the four patients admitted postoperatively for surgery other than kidney transplantation) were admitted to the ICU for medical complications. Their ICU mortality (16%) was comparable to the mortality reported from general medical ICU.3334 Infections were the predominant cause of mortality. A longer duration of immunosuppression was the main characteristic differentiating this group from group 1. The ICU outcome of patients 60 years old or older was equivalent to that of younger patients. The levels of BUN and serum creatinine on admission to the ICU were not predictive of a poor outcome ( Table 5 ). The APACHE II scores on admission were significantly higher in nonsurvivors than in survivors. Mechanical ventilation was not predictive of a worse outcome. Although all the nonsurvivors (eight patients) received mechanical ventilation, 21 other patients who required ventilatory support survived. The same observation is applicable to renal replacement therapy in this study.
The lack of any similar study precluded a comparison of our experience with that of others. Further studies will be necessary to validate our results.
